IPO Announced
Kailera Therapeutics IPO
US$625m raised
Lodged 16 Apr 2026 · NASDAQ: KLRA
Advisers
Lead managers
- Lead manager
- Legal adviser
- Issuer
- Kailera Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech
- Amylyx Pharmaceuticals equity raising Aug 2026 · US$575m · Biotech
- Candid Therapeutics placement Mar 2026 · US$505m · Biotech
- ADARx Pharmaceuticals IPO Sep 2026 · US$446m · Biotech
- Generate Biomedicines IPO Feb 2026 · US$400m · Biotech
Sources
- Apr 2026 William Blair: Kailera Therapeutics Initial Public Offering williamblair.com
- 17 Apr 2026 Final IPO prospectus (424B4), Kailera Therapeutics, Inc. sec.gov




